Macular retinal ganglion cell–inner plexiform layer thickness in patients on hydroxychloroquine therapy

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 1, 2015, Pages 396-402

  Lee, Min Gyu ^a   Kim, Sang Jin ^a   Ham, Don Il ^a   Kang, Se Woong ^a   Kee, Changwon ^a   Lee, Jaejoon ^a   Cha, Hoon Suk ^a   Koh, Eun Mi ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Hydroxychloroquine; Hydroxychloroquine retinopathy; Retinal ganglion cell

Indexed keywords

HYDROXYCHLOROQUINE; ANTIRHEUMATIC AGENT;

ADULT; ARTICLE; AUTOFLUORESCENCE IMAGING; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EXPOSURE; EYE FUNDUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIMETRY; PRIORITY JOURNAL; RETINA INNER PLEXIFORM LAYER; RETINAL THICKNESS; RETINOPATHY; RETROSPECTIVE STUDY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL SYSTEM EXAMINATION; CHEMICALLY INDUCED; DRUG EFFECTS; FOLLOW UP; NERVE FIBER; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PROCEDURES; RETINA GANGLION CELL; RETINAL DISEASES; RHEUMATIC DISEASES;

ADULT; ANTIRHEUMATIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYCHLOROQUINE; MALE; NERVE FIBERS; RETINAL DISEASES; RETINAL GANGLION CELLS; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84921508059     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-15138     Document Type: Article

References (31)

1. Bernstein HN. Chloroquine ocular toxicity. Surv Ophthalmol. 1967;12:415-447.
2. Mavrikakis I, Sfikakis PP, Mavrikakis E, et al. The incidence of irreversible retinaltoxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology. 2003;110:1321- 1326.
3. Levy GD, Munz SJ, Paschal J, et al. Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice. Arthritis Rheum. 1997;40:1482-1486.
4. Wolfe F, Marmor MF. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2010;62:775-784.
5. Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF. American Academy of Ophthalmology. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology. 2011;118:415-422.
6. Wetterholm DH, Winter FC. Histopathology of chloroquine retinal toxicity. Arch Ophthalmol. 1964;71:82-87.
7. Bernstein HN, Ginsberg J. The pathology of chloroquine retinopathy. Arch Ophthalmol. 1964;71:238-245.
8. Ramsay MS, Fine BS. Chloroquine toxicity in the human eye. Am J Ophthalmol. 1972;73:229-235.
9. Rosenthal AR, Kolb H, Bergsma D, Huxsoll D, Hopkins JL. Chloroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci. 1978;17:1158-1175.
10. Hallberg A, Naeser P, Andersson A. Effects of long-term chloroquine exposure on the phospholipid metabolism in retina and pigment epithelium of the mouse. Acta Ophthalmol (Copenh). 1990;68:125-130.
11. Pasadhika S, Fishman GA, Choi D, Shahidi M. Selective thinning of the perifoveal inner retina as an early sign of hydroxychloroquine retinal toxicity. Eye (Lond). 2010;24: 756-762.
12. Jeoung JW, Choi YJ, Park KH, Kim DM. Macular ganglion cell imaging study: glaucoma diagnostic accuracy of spectraldomain optical coherence tomography. Invest Ophthalmol Vis Sci. 2013;54:4422-4429.
13. Kim NR, Lee ES, Seong GJ, Kim JH, An HG, Kim CY. Structurefunction relationship and diagnostic value of macular ganglion cell complex measurement using Fourier-domain OCT in glaucoma. Invest Ophthalmol Vis Sci. 2010;51:4646-4651.
14. Tan O, Chopra V, Lu AT, et al. Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography. Ophthalmology. 2009;116:2305-2314.
15. Mwanza JC, Durbin MK, Budenz DL, et al. Glaucoma diagnostic accuracy of ganglion cell-inner plexiform layer thickness: comparison with nerve fiber layer and optic nerve head. Ophthalmology. 2012;119:1151-1158.
16. Marmor MF. Comparison of screening procedures in hydroxychloroquine toxicity. Arch Ophthalmol. 2012;130:461-469.
17. Marmor MF, Hu J. Effect of disease stage on progression of hydroxychloroquine retinopathy. JAMA Ophthalmol. 2014; 132:1105-1112.
18. Mwanza JC, Oakley JD, Budenz DL, Chang RT, Knight OJ, Feuer WJ. Macular ganglion cell-inner plexiform layer: automated detection and thickness reproducibility with spectral domain-optical coherence tomography in glaucoma. Invest Ophthalmol Vis Sci. 2011;52:8323-8329.
19. Potts AM. Further studies concerning the accumulation of polycyclic compounds on uveal melanin. Invest Ophthalmol Vis Sci. 1964;3:399-404.
20. Potts AM. The reaction of uveal pigment in vitro with polycyclic compounds. Invest Ophthalmol Vis Sci. 1964;3: 405-416.
21. Gonasum LM, Potts AM. In vitro inhibition of protein synthesis in the retinal pigment epithelium by chloroquine. Invest Ophthalmol Vis Sci. 1974;13:107-115.
22. Abraham R, Hendy RJ. Irreversible lysosomal damage induced by chloroquine in the retinae of pigmented and albino rats. Exp Mol Pathol. 1970;12:185-200.
23. Hodgkinson BJ, Kolb H. A preliminary study of the effect of chloroquine on the rat retina. Arch Ophthalmol. 1970;84: 509-515.
24. Gleiser CA, Dukes TW, Lawwill T, Read WK, Bay WW, Brown RS. Ocular changes in swine associated with chloroquine toxicity. Am J Ophthalmol. 1969;67:399-405.
25. Ulviye Y, Betul T, Nur TH, Selda C. Spectral domain optical coherence tomography for early detection of retinal alterations in patients using hydroxychloroquine. Indian J Ophthalmol. 2013;61:168-171.
26. Pasadhika S, Fishman GA. Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures. Eye (Lond). 2010;24:340-346.
27. Milam AH, Li ZY, Fariss RN. Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res. 1998;17: 175-205.
28. Vámos R, Tátrai E, Németh J, Holder GE, DeBuc DC, Somfai GM. The structure and function of the macula in patients with advanced retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2011;52:8425-8432.
29. Santos A, Humayun MS, de Juan E Jr, et al. Preservation of the inner retina in retinitis pigmentosa. A morphometric analysis. Arch Ophthalmol. 1997;115:511-515.
30. Marc RE, Jones BW, Watt CB, Strettoi E. Neural remodeling in retinal degeneration. Prog Retin Eye Res. 2003;22:607-655.
31. Hood DC, Lin CE, Lazow MA, Locke KG, Zhang X, Birch DG. Thickness of receptor and post-receptor retinal layers in patients with retinitis pigmentosa measured with frequencydomain optical coherence tomography. Invest Ophthalmol Vis Sci. 2009;50:2328-2336.